Giving Compass’ Take:
• Pacific Standard reports on infections with Naegleria fowleri, the so-called brain-eating amoeba. While rare, it is also deadly.
• The author, who studies parasites, notes that there is no medication available with proven efficacy yet. How can donors play a role in supporting medical research that leads to solutions?
Composed of a single cell, amoeba seem harmless enough: They look like playful critters waltzing under the spotlight of a microscope until they come upon a group of bacteria. Then, these previously innocuous amoeba suddenly morph into sinister blobs, engulfing the bacteria and slowly ripping them apart with a bevy of digestive enzymes. It’s hard to cry over murdered bacteria, but the digestive power of amoeba is the stuff of nightmares when it plays out in a human brain.
Infections with Naegleria fowleri, the so-called brain-eating amoeba, are extremely rare, but also extremely deadly. Only 146 cases have been reported in the United States since 1962, with only four surviving the infection; so there is a 97 percent chance of death. Sadly, on July 22nd, a 59-year-old North Carolina man became the first person to die of the infection this year after swimming in a lake at a water park.
I study parasites and have a particular interest in those that target the brain, which is why this amoeba captured my interest.
Read the full article on Naegleria fowleri by Bill Sullivan at Pacific Standard.
Since you are interested in Health, have you read these selections from Giving Compass related to impact giving and Health?
Are you ready to give?
If you are ready to take action and invest in causes for Diseases and Cures, check out these Giving Funds, Charitable Organizations and Projects related to Diseases and Cures.